デフォルト表紙
市場調査レポート
商品コード
1607752

医療用プロペラントの世界市場:タイプ・用途・エンドユーザー (医療機器製造業者・CMO・研究ラボ)・地域別の予測 (~2032年)

Global Medical Propellants Market Research Report Information by Type, By Application, By End User (Medical Device Companies, Contract Manufacturing Organization, and Research Laboratories) And by Region Forecast Till 2032


出版日
ページ情報
英文 116 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医療用プロペラントの世界市場:タイプ・用途・エンドユーザー (医療機器製造業者・CMO・研究ラボ)・地域別の予測 (~2032年)
出版日: 2024年11月21日
発行: Market Research Future
ページ情報: 英文 116 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療用プロペラントの市場規模は、2023年の2億7,000万米ドル、2024年の3億米ドルから、予測期間中は10.16%のCAGRで推移し、2032年には7億2,000万米ドルの規模に成長すると予測されています。

医療用プロペラントの市場は、慢性閉塞性肺疾患 (COPD) や喘息を含む呼吸器疾患の有病率の上昇によって大きな影響を受ける可能性があります。この影響とは、プロペラントを利用する吸入ベースの治療薬やデバイスへの需要の増加です。呼吸器系疾患が流行する中で、肺に薬剤を供給するために不可欠なデバイスである吸入器の需要が増加していますが、これらの吸入器は、薬剤を効果的に送達するためにプロペラントを使用しています。

地域別展望

北米地域が2023年に最大の市場シェアを示しています。また、成長率では、欧州が予測期間中にもっとも高いCAGRを示すと予測されています。

北米市場は力強い成長を特徴としており、これは支持的な規制環境、技術の進歩、ヘルスケア要件の増加によってもたらされています。また、研究開発への多額の投資と高度なヘルスケアインフラによって最先端の医療用プロペラントの開発が可能となっており、同地域市場を牽引しています。

欧州の医療用プロペラント市場の特徴は、プロペラント処方の開発が進んでいることです。欧州の製薬部門は成熟しており、強力な流通チャネル、提携、厳格な欧州規制の遵守が保証されています。このため、製品は高い安全性と有効性の基準を満たしており、消費者の信頼を得ています。高品質の吸入器に対する需要は、呼吸器疾患の有病率上昇を促進する高齢化によってさらに高まっています。

アジア太平洋地域も予測期間中、さまざまな主要要因によって力強い成長を示すと予測されています。医療用プロペラントを利用する高機能吸入器の需要は、中国、インド、日本などの国における医療インフラの急速な拡大や医療インフラへの投資の増加によって牽引されています。

当レポートでは、世界の医療用プロペラントの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

  • 促進要因
    • 喘息やCOPDなどの呼吸器疾患の発生率の上昇
    • 吸入器の技術的進歩
    • 予防ヘルスケアに関する意識の向上
  • 抑制要因
    • 先進的なプロペラントの高コスト
  • 機会
    • 新興市場

第5章 市場要因分析

  • ポーターのファイブフォース分析
  • COVID-19が世界の医療用プロペラント市場に与える影響

第6章 世界の医療用プロペラント市場:タイプ別

  • 概要
  • HFA 134A
  • HFA 227EA
  • HFA 152A

第7章 世界の医療用プロペラント市場:用途別

  • 概要
  • プレス定量吸入器
  • 呼吸作動式定量吸入器

第8章 世界の医療用プロペラント市場:エンドユーザー別

  • 概要
  • 医療機器企業
  • CMO
  • 研究ラボ

第9章 世界の医療用プロペラント市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他
  • その他の地域
    • 中東・アフリカ
    • 南米

第10章 競合情勢

  • 市場シェア分析
  • 競合ダッシュボード
  • 公開企業の株式概要
  • 比較分析:主要企業の財務
  • 主な展開・成長戦略

第11章 企業プロファイル

  • KOURA
  • SRF
  • DAIKIN CHEMICAL EUROPE GMBH
  • LINDE PLC
  • XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD
  • JIANGSU JULY CHEMICAL CO., LTD.
  • BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.
  • ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.
  • ZHEJIANG FOTECH INTERNATIONAL CO., LTD
  • CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.

第12章 データの引用

図表

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 4 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (METRIC TON)
  • TABLE 6 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (METRIC TON)
  • TABLE 8 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (METRIC TON)
  • TABLE 10 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL MEDICAL PROPELLANTS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL MEDICAL PROPELLANTS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL MEDICAL PROPELLANTS MARKET, FOR MEDICAL DEVICE COMPANIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL MEDICAL PROPELLANTS MARKET, FOR CONTRACT MANUFACTURING ORGANIZATION (CMO), BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL MEDICAL PROPELLANTS MARKET, FOR RESEARCH LABORATORIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 19 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 20 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 21 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 22 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 23 US: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 24 US: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 25 US: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 26 US: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 27 CANADA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 28 CANADA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 29 CANADA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 30 CANADA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 31 EUROPE: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 32 EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 33 EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 34 EUROPE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 35 EUROPE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 36 GERMANY: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 37 GERMANY: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 38 GERMANY: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 39 GERMANY: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 40 FRANCE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 41 FRANCE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 42 FRANCE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 43 FRANCE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 44 UK: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 45 UK: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 46 UK: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 47 UK: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 48 ITALY MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 49 ITALY MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 50 ITALY MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 51 ITALY: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 52 SPAIN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 53 SPAIN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 54 SPAIN: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 55 SPAIN: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 56 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 57 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 58 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 59 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 60 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 61 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 62 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 63 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 64 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 65 CHINA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 66 CHINA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 67 CHINA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 68 CHINA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 69 INDIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 70 INDIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 71 INDIA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 72 INDIA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 73 JAPAN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 74 JAPAN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 75 JAPAN: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 76 JAPAN: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 77 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 78 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 79 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 80 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 81 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 82 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 83 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 84 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 85 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 86 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 87 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 88 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 89 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 90 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 91 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 92 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 93 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 94 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 95 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 96 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 97 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 98 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 99 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
  • TABLE 100 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 101 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 102 FACILITY EXPANSION
  • TABLE 103 KOURA: PRODUCT OFFERED
  • TABLE 104 KOURA: KEY DEVELOPMENT
  • TABLE 105 SRF: PRODUCTS OFFERED
  • TABLE 106 DAIKIN CHEMICAL EUROPE GMBH: PRODUCT OFFERED
  • TABLE 107 LINDE PLC: PRODUCT OFFERED
  • TABLE 108 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD: PRODUCTS OFFERED
  • TABLE 109 JIANGSU JULY CHEMICAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 110 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.: PRODUCTS OFFERED
  • TABLE 111 ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 112 ZHEJIANG FOTECH INTERNATIONAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 113 CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL MEDICAL PROPELLANTS MARKET: STRUCTURE
  • FIGURE 2 GLOBAL MEDICAL PROPELLANTS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MEDICAL PROPELLANTS MARKET
  • FIGURE 6 GLOBAL MEDICAL PROPELLANTS MARKET, TYPE, 2023 & 2032 (USD MILLION)
  • FIGURE 7 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY TYPE,
  • FIGURE 9 GLOBAL MEDICAL PROPELLANTS MARKET, APPLICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY APPLICATION,
  • FIGURE 12 GLOBAL MEDICAL PROPELLANTS MARKET, END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 13 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY END USER,
  • FIGURE 15 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 16 GLOBAL MEDICAL PROPELLANTS MARKET SHARE, BY REGION, 2023 (% SHARE)
  • FIGURE 17 NORTH AMERICA MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 18 NORTH AMERICA MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 19 NORTH AMERICA MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 20 EUROPE MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 21 EUROPE MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 22 EUROPE MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 26 REST OF THE WORLD: MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 27 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 28 REST OF THE WORLD MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 29 GLOBAL MEDICAL PROPELLANTS MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 30 COMPETITOR DASHBOARD: GLOBAL MEDICAL PROPELLANTS MARKET
  • FIGURE 31 KOURA: SWOT ANALYSIS
  • FIGURE 32 SRF: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 33 LINDE PLC SWOT ANALYSIS
  • FIGURE 34 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD: SWOT ANALYSIS
  • FIGURE 35 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.: SWOT ANALYSIS
  • FIGURE 36 ZHEJIANG FOTECH INTERNATIONAL CO., LTD.: SWOT ANALYSIS
目次
Product Code: MRFR/HC/26934-CR

Global Medical Propellants Market Research Report Information by Type (HFA 134A, HFA 227EA, HFA152A), By Application (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By End User (Medical Device Companies, Contract Manufacturing Organization (CMO), and Research Laboratories) And by Region (North America, Europe, Asia-Pacific, And Rest Of The World) Forecast Till 2032

Market Overview

In 2023, the Medical Propellants Market was estimated to be worth USD 0.27 billion. The industry is anticipated to experience a compound annual growth rate (CAGR) of 10.16% from USD 0.30 billion in 2024 to USD 0.72 billion by 2032 during the forecast period (2024-2032). The global metered-dose inhaler market is experiencing growth due to the increasing prevalence of respiratory conditions, including chronic obstructive pulmonary disease and asthma, as well as technological innovation in inhalation devices.

There is a significant likelihood that the medical propellants market will be significantly affected by the rising prevalence of respiratory disorders, including chronic obstructive pulmonary disease (COPD) and asthma. This effect is primarily the result of an increase in the demand for inhalation-based remedies and devices that utilize propellants. The demand for inhalers, which are essential devices for delivering medication to the lungs, is on the rise as respiratory maladies become more prevalent. These inhalers employ propellants to ensure that the medication is delivered effectively.

Market segment insights

The Medical Propellants Market has been segmented into HFA 134A, HFA 227EA, and HFA-152A based on type.

The Market has been segmented into manual metered dose inhalers and breath metered dose inhalers based on application.

According to the end user, the market has been divided into three categories: medical device companies, contract manufacturing organizations (CMOs), and research laboratories.

Regional Perspectives

In 2023, the market share that North America possessed was the most significant. Nevertheless, Europe is anticipated to experience the most significant compound annual growth rate (CAGR) during the 2024-2032 forecast period.

Robust growth is the hallmark of the Medical Propellants market in North America, which is driven by a supportive regulatory environment, technological advancements, and increased healthcare requirements. Additionally, the market is driven by the development of state-of-the-art Medical Propellants, which is made possible by a substantial investment in research and development and a sophisticated healthcare infrastructure.

Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe, follows the Americas region. The Medical Propellants market in Europe is characterized by the ongoing development of propellant formulations. The pharmaceutical sector in Europe is mature, which guarantees a strong distribution channel, collaborations, and adherence to stringent European regulations. This ensures that the products meet high safety and efficacy standards, which instills confidence in consumers. The demand for sophisticated, high-quality inhalers is further exacerbated by the aging population, which is driving the rise in the prevalence of respiratory diseases.

Over the forecast period, the Asia-Pacific region is anticipated to experience robust development, which is driven by a variety of key factors. It is also projected to be the fastest-growing region. The demand for sophisticated inhalers that utilize medical propellants is being driven by the rapid expansion of healthcare infrastructure and the increasing investments in healthcare infrastructure in countries such as China, India, and Japan.

Major Players

Koura (US), SRF (India), DAIKIN (Japan), Linde PLC (UK), Xiamen Juda Chemical & Equipment Co., Ltd. (China), Jiangsu July Chemical Co., Ltd. (China), Beijing Yuji Technology Development Co., Ltd. (China), Zhejiang Jushen New Material Technology Co., Ltd. (China), Zhejiang fotech international co., ltd. (China), and Changshu 3F Fluorochemical Industry Co., Ltd. (China) are among the key companies in the Medical Propellants Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION

A propellant is a substance used to propel a medication from an aerosol canister or inhaler. These propellants are typically gases that help deliver medication in a fine mist or spray to ensure it can be effectively inhaled or applied.

  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 Data Mining Process
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 Secondary Research data flow:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 Primary Research DATA FLOW:
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 Revenue Analysis Approach
  • 3.7 DATA FORECASTING
    • 3.7.1 Data forecasting Type
  • 3.8 DATA MODELING
    • 3.8.1 microeconomic factor analysis:
    • 3.8.2 Data modeling:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 Rising incidence of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)
    • 4.2.2 Technological Advancements in Inhalation Devices
    • 4.2.3 Increased awareness about preventive healthcare
  • 4.3 RESTRAINTS
    • 4.3.1 High costs of advanced propellants
  • 4.4 OPPORTUNITY
    • 4.4.1 Emerging markets offer significant growth opportunities

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 Threat of New Entrants
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 Threat of Substitutes
    • 5.1.4 Bargaining Power of Buyers
    • 5.1.5 Intensity of Rivalry
  • 5.2 IMPACT OF COVID-19 ON THE GLOBAL MEDICAL PROPELLANTS MARKET

6 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 HFA 134A
  • 6.3 HFA 227EA
  • 6.4 HFA-152A

7 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 PRESS METERED DOSE INHALERS
  • 7.3 BREATH ACTUATED METERED DOSE INHALERS

8 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 MEDICAL DEVICE COMPANIES
  • 8.3 CONTRACT MANUFACTURING ORGANIZATION (CMO)
  • 8.4 RESEARCH LABORATORIES

9 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 us
    • 9.2.2 canada
  • 9.3 EUROPE
    • 9.3.1 Germany
    • 9.3.2 France
    • 9.3.3 UK
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 ASIA-PACIFIC
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia-Pacific
  • 9.5 REST OF THE WORLD
    • 9.5.1 middle east & africa
    • 9.5.2 south america

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS,
  • 10.3 COMPETITOR DASHBOARD
  • 10.4 PUBLIC PLAYERS STOCK SUMMARY
  • 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.6.1 Facility expansion

11 COMPANY PROFILES

  • 11.1 KOURA
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 products OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 SRF
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 Product OFFERed
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 KEY STRATEGIES
  • 11.3 DAIKIN CHEMICAL EUROPE GMBH
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 productS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 KEY STRATEGIES
  • 11.4 LINDE PLC
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 productS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 JIANGSU JULY CHEMICAL CO., LTD.
    • 11.6.1 COMPANY OVERVIEw
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 Product OFFERed
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY STRATEGIES
  • 11.7 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 Product OFFERed
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 KEY STRATEGIES
  • 11.9 ZHEJIANG FOTECH INTERNATIONAL CO., LTD
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 Product OFFERed
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 Product OFFERed
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES

12 DATA CITATIONS